Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 4Warts 1Uterine Cervical Neoplasms 1Retinoblastoma 1Prostatic Diseases 1Papillomavirus Infections 1Esophageal Neoplasms 1Deglutition Disorders 1

Interventions

Data Collection 9human papillomavirus vaccine, L1 type 16, 18 4Blood Specimen Collection 4Surveys and Questionnaires 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Specimen Handling 2Polymerase Chain Reaction 2Papillomavirus Vaccines 2Observation 2Colposcopy 2Viral Load 1Vaginal Smears 1Vaccination 1Restraint, Physical 1Papanicolaou Test 1Methods 1Mass Screening 1Liquid Biopsy 1Interviews as Topic 1Independent Medical Evaluation 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus DNA Tests 1Histological Techniques 1High-Energy Shock Waves 1Gene Expression Profiling 1Focus Groups 1Flow Cytometry 1Early Intervention, Educational 1Cytological Techniques 1Cryotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Papillomavirus Infections × Cryotherapy × Clear all
NCT06005389 2023-08-22

Serum Galectin-3 as a Marker of Human Papillomavirus Infection

Assiut University

Completed
100 enrolled

Warts, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡